.
  • NIFTY 25,056.20 +87.80 (+0.35%)
  • SENSEX 82,132.25 +374.52 (+0.46%)
 
BSE
NSE

Monday, July 21, 2025 , BSE Sensex : 82,132.25 82,132.25(0.46%) , Adani Ports : 1,443.10 1,443.10(0.02%) , Asian Paints : 2,372.50 2,372.50(-0.40%) , Axis Bank : 1,096.60 1,096.60(-0.23%) , Bajaj Finance : 947.50 947.50(0.60%) , Bajaj Finserv : 2,047.50 2,047.50(0.89%) , Bharat Electron : 398.30 398.30(0.91%) , Bharti Airtel : 1,908.30 1,908.30(0.38%) , Eternal Ltd : 264.95 264.95(2.95%) , HCL Technologies : 1,534.60 1,534.60(-0.93%) , HDFC Bank : 1,995.95 1,995.95(1.97%) , Hind. Unilever : 2,464.55 2,464.55(-0.98%) , ICICI Bank : 1,460.10 1,460.10(2.36%) , Infosys : 1,581.00 1,581.00(-0.35%) , ITC : 421.40 421.40(-0.30%) , Kotak Mah. Bank : 2,162.00 2,162.00(0.99%) , Larsen & Toubro : 3,488.30 3,488.30(0.70%) , M & M : 3,230.05 3,230.05(1.13%) , Maruti Suzuki : 12,407.50 12,407.50(-0.12%) , NTPC : 340.95 340.95(-0.32%) , Power Grid Corpn : 295.40 295.40(0.46%) , Reliance Industr : 1,444.80 1,444.80(-2.17%) , St Bk of India : 822.50 822.50(-0.10%) , Sun Pharma.Inds. : 1,696.15 1,696.15(0.17%) , Tata Motors : 682.75 682.75(0.38%) , Tata Steel : 163.85 163.85(0.83%) , TCS : 3,167.95 3,167.95(-0.69%) , Tech Mahindra : 1,539.20 1,539.20(-0.60%) , Titan Company : 3,397.55 3,397.55(-0.13%) , Trent : 5,385.20 5,385.20(0.27%) , UltraTech Cem. : 12,633.40 12,633.40(1.08%) ,

Nifty 50 : 25,056.20 87.80(0.35%) , Adani Enterp. : 2,616.40 20.30(0.78%) , Adani Ports : 1,441.80 -1.30(-0.09%) , Apollo Hospitals : 7,301.50 -2.00(-0.03%) , Asian Paints : 2,370.80 -11.60(-0.49%) , Axis Bank : 1,093.90 -5.40(-0.49%) , Bajaj Auto : 8,393.00 45.50(0.55%) , Bajaj Finance : 946.40 4.40(0.47%) , Bajaj Finserv : 2,048.80 19.20(0.95%) , Bharat Electron : 397.55 2.80(0.71%) , Bharti Airtel : 1,908.70 7.70(0.41%) , Cipla : 1,476.50 -5.80(-0.39%) , Coal India : 385.90 -2.60(-0.67%) , Dr Reddy's Labs : 1,250.70 -6.80(-0.54%) , Eicher Motors : 5,598.50 -29.00(-0.52%) , Eternal Ltd : 265.15 7.95(3.09%) , Grasim Inds : 2,741.30 12.80(0.47%) , HCL Technologies : 1,534.50 -14.30(-0.92%) , HDFC Bank : 1,995.70 38.30(1.96%) , HDFC Life Insur. : 746.50 7.00(0.95%) , Hero Motocorp : 4,404.10 7.40(0.17%) , Hind. Unilever : 2,466.60 -23.00(-0.92%) , Hindalco Inds. : 684.00 8.10(1.20%) , ICICI Bank : 1,459.80 34.00(2.38%) , IndusInd Bank : 846.75 -23.30(-2.68%) , Infosys : 1,581.10 -5.00(-0.32%) , ITC : 421.80 -0.95(-0.22%) , Jio Financial : 318.15 1.30(0.41%) , JSW Steel : 1,028.10 -6.30(-0.61%) , Kotak Mah. Bank : 2,160.00 19.50(0.91%) , Larsen & Toubro : 3,485.00 20.20(0.58%) , M & M : 3,226.60 34.20(1.07%) , Maruti Suzuki : 12,382.00 -37.00(-0.30%) , Nestle India : 2,466.00 -6.20(-0.25%) , NTPC : 340.80 -1.30(-0.38%) , O N G C : 244.92 -1.39(-0.56%) , Power Grid Corpn : 295.15 1.00(0.34%) , Reliance Industr : 1,444.30 -31.70(-2.15%) , SBI Life Insuran : 1,787.90 -0.50(-0.03%) , Shriram Finance : 648.25 2.75(0.43%) , St Bk of India : 821.70 -1.65(-0.20%) , Sun Pharma.Inds. : 1,694.40 0.80(0.05%) , Tata Consumer : 1,084.70 -11.20(-1.02%) , Tata Motors : 682.00 1.75(0.26%) , Tata Steel : 164.07 1.70(1.05%) , TCS : 3,168.10 -21.80(-0.68%) , Tech Mahindra : 1,543.60 -5.30(-0.34%) , Titan Company : 3,393.50 -9.40(-0.28%) , Trent : 5,385.00 10.00(0.19%) , UltraTech Cem. : 12,641.00 143.00(1.14%) , Wipro : 262.20 -4.75(-1.78%) , Monday, July 21, 2025

Home >> Markets >> Equities >> News - News Details
DAILY MARKET TRACKER
MARKET ANALYSIS
NEWS
CORPORATE INFO
CORPORATE ACTIONS
OTHER MARKETS
Corporate News
16-Jul-2025     13:35
Suven Life Sciences updates on Phase-2b clinical trial of Ropanicant

Suven Life Sciences announced that the first patient has been randomized in its Phase-2b clinical trial evaluating Ropanicant, a novel oral α4β2 nicotinic acetylcholine receptor (nAChR) antagonist, for the treatment of Major Depressive Disorder (MDD).

 The Phase-2b double blinded, placebo controlled study builds on the positive results of the completed Phase-2a trial, which demonstrated favorable safety, clinically meaningful and significant improvement in depressive symptoms from baseline based on the Montgomery 'sberg Depression Rating Scale (MADRS) score, with indication of rapid onset of action in MDD patients distinguishing Ropanicant from existing standard therapies. Insights from Phase-2a evolved the study design, dose selection, and dosing regimen for the current Phase 2b trial being conducted in exclusively in USA under FDA IND.

Randomizing the first patient in our Phase-2b study of Ropanicant is an important milestone for Suven Life Sciences. It reflects our continued commitment to developing innovative treatments for patients suffering from MDD.' said  Venkat Jasti, Chairman and MD of Suven Life Sciences.

Powered by Capital Market - Live News